Health News Releases

  • Today January 27
July 26, 2022 15:00
EssilorLuxottica Modernizes Order Processing With Boomi’s Intelligent Integration Platform
Boomi™, the intelligent connectivity and automation leader, today announced that EssilorLuxottica, a global leader in the eyewear market, has implemented Boomi's integration platform as a service (iPa
July 25, 2022 16:23
Increased Adoption of Imaging Technology To Detect And Monitor Ailment Severity Is Accelerating The Mobile Imaging Services Industry In Asia Pacific: Scrutinized Report By Fact.MR
The mobile imaging services market is predicted to account for USD 2.7 billion in 2032, up from USD 1.9 billion in 2022, advancing at a CAGR of 3.9% during the forecast period (2022-2032). The incr
July 22, 2022 16:10
Takeda Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating HYQVIA® for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda (TSE:4502/NYSE:TAK) today announced that ADVANCE-1, a randomized, placebo-controlled, double-blind Phase 3 clinical trial evaluating HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombina
July 22, 2022 13:45
Neuraptive Therapeutics Announces First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma
Neuraptive Therapeutics, Inc. (Neuraptive), a clinical-stage biotechnology company dedicated to developing novel therapeutics and medical products for the treatment of peripheral nerve injuries (PNI),
Digital Industries at Siemens Korea awarded students at the 9th Smart NC Contest Award Ceremony held
July 22, 2022 09:55
Siemens Korea Digital Industries Holds 9th Smart NC Contest Award Ceremony
Digital Industries (DI) of Siemens Korea (Siemens Ltd. Seoul·SLS) held the 9th Smart Numerical Control (NC) Contest Award Ceremony on July 21 at the Korea Digital Enterprise Experience Center (KDEXc)
July 22, 2022 09:40
DentalMonitoring: July Product Announcements
DentalMonitoring has launched a breakthrough service for dental professionals and industry partners: the DM Intelligent Platform is now the only digital workflow which can interface and integrate with
July 21, 2022 16:20
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs
February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”) entered a strategic collaboration with LiberoThera Co., Ltd (“LiberoThera”) to co-develop fully human GPCR antibodies u
July 21, 2022 14:30
Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
Masimo (NASDAQ: MASI) today announced the findings of a randomized, controlled trial published in the Journal of Clinical Anesthesia in which Dr. Melody H.Y. Long and colleagues from the KK Women’s an
July 21, 2022 09:40
STALICLA Awarded EUR 1.7 Million to Lead Computational Drug Repositioning Activities in EU-funded REPO4EU Project
REPO4EU consortium seeks to address the urgent need for new cost-effective therapies, as well as to improve existing treatments through international cooperation, pooling research and innovation exper
July 20, 2022 14:00
Prestigous West Coast Academic Medical Center Renews Six-Figure, Multi-Year Agreement For Privacy And Security Managed Services
CynergisTek, Inc. (NYSE American: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issue
July 20, 2022 10:30
SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that a phase III clinical trial for SINOVAC’s inactivated quadriva
July 20, 2022 09:05
Pharma Proposes to Work with G7 and G20 on a Joint Solution for Better Access to Vaccines and Treatments Around the World for Future Pandemics
The biopharmaceutical industry launched today the “Berlin Declaration - biopharmaceutical industry vision for equitable access in pandemics” and presents global leaders with a proposal that could help
July 19, 2022 19:00
Covac Global Redefines Duty of Care With No Hospitalization Requirement for Repatriation and Newly-added Coverage for Monkeypox
Covac Global, the Premier Medical Evacuation Membership, pioneered the simple approach to medical evacuation with “Get Sick, Get Home” requiring no hospitalization, announces it will include repatriat
July 19, 2022 14:21
Peoplecare Chooses Boomi and Atturra To Connect Member Data For Personalized Health Fund Experiences
Boomi™, the intelligent connectivity and automation leader, today announced that Peoplecare, an Australian health insurance mutual fund, implemented The Boomi AtomSphere™ Platform to deliver improved
July 18, 2022 21:15
Q2 Update by PQE Group: Two Acquisitions’ Announcements With United Pharma Technologies Inc. & Quintian Pharma, and New Two Offices
The first half of 2022 has closed highly positively for PQE Group, the global women-owned quality consulting company for Lifesciences. The Italian parent Group, after having concluded 2021 with + 20%
July 18, 2022 16:11
Growing Prevalence of Bleeding Disorders and Advancements in Treatments to Bolster Market Revenue; Reaching USD 19.9 Bn: Report Fact.MR
As per an in-depth industry analysis on bleeding disorders treatment by Fact.MR, market research and competitive intelligence provider, the global market is anticipated to expand at a CAGR of 6.7% ove
July 15, 2022 11:00
SINOVAC COVID-19 Vaccine Is Authorized for Emergency Use in Kids Aged 3-5 In Brazil
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that its COVID-19 vaccine (CoronaVac) has been approved by the Bra
July 13, 2022 16:45
Extension of the postponement of the settlement of Vifor Pharma tender offer
Regulatory News: AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR CSL Limited (ASX: CSL; USOTC:CSLLY) today announced an update regarding the Vifor Pharma AG acquisition. On January 18, 2022, CSL B
July 13, 2022 11:30
Fluke Biomedical OneQA Now Supports Patient Monitor Testing
Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator. Fluke Biomedical OneQA is an industry-leading quality
July 13, 2022 10:10
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
The market-leader for antimicrobial proteins, Lysando AG, has appointed Sang Jung Kim as new member to the Board of Directors. Kim has a strong Biotech background and a proven successful track record
July 12, 2022 10:15
Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange
Takeda Pharmaceutical Company Limited (“Takeda”) (TOKYO:4502/NYSE:TAK) today announced that it has filed its Corporate Governance Report with the Tokyo Stock Exchange (“TSE”) in accordance with the re
July 12, 2022 09:24
Why Oral Care is Receiving the Most Support Among Different Types of Dental Laboratories; Sales To Top With USD 5.3 Bn by 2032: Latest Study by Fact.MR
The dental laboratories market revenues were estimated at USD 29.6 Bn in 2021 and are anticipated to grow at a CAGR of 5.6% from 2022-2032, according to a recently published Fact.MR report. By the
July 08, 2022 14:10
New Study shows Urolithin A (Mitopure®) Improves Mitochondrial Health, Reduces Joint Cartilage Damage and Alleviates Pain in Osteoarthritis
Amazentis, a spin-off of the Swiss Federal Institute of Technology (EPFL) pioneering scientific breakthroughs in cellular health and nutrition, announced today that the peer-reviewed journal Aging Cel
July 07, 2022 10:10
KBI Biopharma and Selexis Hold Joint Ribbon Cutting of the Expanded State-of-the-Art Facility in Geneva, Switzerland
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, held a joint ribbon-cutting ceremony yesterday at their new state-of-the-art facility in Geneva, Switzerland. Designed to direc
July 07, 2022 09:20
Growing Applications In Clinical Research Activities Have Significant Importance In Developments Of Healthcare Automation Market With Anticipation Of USD 88.9 Bn: Fact.MR
Fact.MR, a market research and competitive intelligence provider, has conducted a comprehensive analysis of the healthcare automation market, which is expected to rise at a CAGR of 8.4% over the forec
July 06, 2022 16:15
Boehringer Ingelheim, Evotec and bioMérieux launch Aurobac, a joint venture to fight Antimicrobial Resistance
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, the life science company Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and bioMérie
July 06, 2022 13:20
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
The collaboration combines Aurigene’s small molecule drug discovery platform and EQRx's pioneering business model to accelerate the development of drug candidates in the areas of oncology and immune-i
(above) Vial filling station at Vetter’s Rankweil site/(below) Area for material preparation at Vett
July 05, 2022 13:25
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills
With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has reached another milestone at its new clinical manu
July 05, 2022 11:40
SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China
A kick off ceremony was held at Gleneagles Hospital Hong Kong (Gleneagles or GHK) for initiating a clinical trial to assess the safety and immunogenicity of the SINOVAC’s Omicron-specific COVID-19 ina
July 01, 2022 15:19
Takeda’s TAKHZYRO® (lanadelumab) Demonstrated Positive Results in the Prevention of HAE Attacks in First and Only Open-Label Phase 3 Trial in Children Ages 2 to <12 Years
Takeda (TSE:4502/NYSE:TAK) today announced late-breaking data from the Phase 3 SPRING study (NCT04070326) presented at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2
July 01, 2022 13:45
Spinal Cord Stimulation Delivers Improved Arm Function
ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces a Na
July 01, 2022 10:00
Medidata Announces Rapid Expansion of its Sensor Cloud Network with the Addition of 10 Health Technology Innovators
Medidata, a Dassault Systèmes company, announced 10 highly innovative organizations have joined its groundbreaking Sensor Cloud Network. AliveCor, Aural Analytics, Biobeat, Blue Spark Technologies, Gl
June 30, 2022 10:55
MRM Health Starts Clinical Trial with Next-Generation Optimized Consortium Therapeutic MH002 in Pouchitis
MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced today that they have received regulatory approval from the Federal A
June 29, 2022 15:55
Walgreens Boots Alliance Concludes Strategic Review and Decides to Retain Ownership of its Successful Boots Business
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced its decision to keep its Boots and No7 Beauty Company businesses under its existing ownership. This marks the conclusion of the review that
June 28, 2022 19:00
Aleph Farms Hires Chief of Regulatory Affairs Ahead of Global Commercialization
Aleph Farms, the first cultivated meat company to grow steaks directly from non-genetically engineered animal cells, today announced the addition of Yifat Gavriel as Chief of Regulatory Affairs and Qu
June 28, 2022 16:00
Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine
Takeda (TSE:4502/NYSE:TAK) (“Takeda”) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that results from a Phase 2 clinical study (AROAAT-2002) of investigational fazirsiran (TAK-999/
June 24, 2022 15:10
Mary Kay Inc. Partners With the Society of Investigative Dermatology (SID) to Award Educational Grants to Academic Research Fellows for Advancement in Research to Promote Skin Health
Mary Kay Inc., a global leader in skincare innovation, recently sponsored and revealed its inaugural Mary Kay Skin Health/Skin Disease Research Grants awardees for researchers conducting groundbreakin
June 23, 2022 09:50
AiVF Raises $25 Million in Series A Round Led by Insight Partners to Help More People Become Parents
AiVF®, developer of the first fully operational AI-based IVF software platform, announced today it has raised $25 million in a Series A round led by Insight Partners, a New York-based venture capital
June 22, 2022 16:02
Asia Specific Biotechnology Instruments Market Is Poised To Exceed USD 40 Bn by 2032; R&D Arms of Major Multinational Pharmaceutical Corporations Fuels The Market: Report by Fact.MR
The Biotechnology Instruments Market revenues were estimated at USD 46.1 Bn in 2021 and is anticipated to grow at a CAGR of 16.4% from 2022-2032, according to a recently published Fact.MR report. By t
June 22, 2022 16:00
Galderma Announces Positive Data From Phase III Trial, Demonstrating Efficacy and Safety of nemolizumab in Patients with Prurigo Nodularis
Galderma today announced the phase III OLYMPIA 2 trial met all primary and key secondary endpoints, showing nemolizumab as monotherapy significantly improved skin lesions and pruritus (itch) compared
June 21, 2022 16:35
Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development
Waters Corporation (NYSE:WAT) announced a collaboration with BioInfra, a pioneering contract research organization (CRO) company for the pharmaceutical and clinical fields, to jointly establish the AS
June 21, 2022 16:16
Companies in the Global Omics Based Clinical Trials Market Expedite Product Innovations to Stay at Forefront; Expected Sales to Reach USD 61.7 Bn By 2032: Fact.MR’s Study
The Omics Based Clinical Trials Market revenues were estimated at USD 26.2 Bn in 2021 and is anticipated to grow at a CAGR of 8.1% from 2022 to 2032, according to a recently published Fact.MR report.
June 21, 2022 15:45
AOP Health Presents Final Results From Its CONTINUATION-PV Study - up to 7.5 Years Treatment With BESREMi® (Ropeginterferon alfa-2b) of Polycythaemia Vera Patients - at EHA 2022 Annual Meeting
AOP Health announced the final results on Ropeginterferon alfa-2b in patients with Polycythaemia Vera (PV) from its CONTINUATION-PV study in an oral presentation at the prestigious EHA (European Hemat
June 20, 2022 16:30
Solasia Pharma: DARVIAS® Injection 135mg (Generic Name: DARINAPARSIN /Development Code: SP-02) Approved in Japan
Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) officially announced today that an organoarsenic drug “DARVIAS® Injection 135mg” (SP
June 20, 2022 14:30
Increasing Prevalence of Diabetic Ketoacidosis Is Expected to Drive Growth of Blood Ketone Meter Market: Fact.MR’s Study
The Blood Ketone Meter market revenues were estimated at US$ 275 Mn in 2021 and are anticipated to grow at a CAGR of 8.1% from 2022-2032 according to a recently published Fact.MR report. By the en
June 17, 2022 17:40
IFPMA: Pharmaceutical Industry Expresses Deep Disappointment With Decision on Waiving Intellectual Property Rights Adopted at the World Trade Organization Ministerial Conference
Today’s decision at the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a TRIPS waiver for COVID-19 vaccines sends the wrong message to those carrying out research and developm
June 16, 2022 15:50
Alvotech, a Global Pureplay Biosimilars Company, to Debut on Nasdaq Under the Ticker ALVO on June 16
Alvotech, a global biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide today announced that its ordinary shares and warrants will begin tra
June 16, 2022 11:55
Saint-Gobain Bioprocess Solutions Business Announces C-Flex® Production Capability in Suwa, Japan
Saint-Gobain Life Sciences today announced the addition of their Suwa, Japan manufacturing facility for the production of C-Flex® TPE tubing for use in bioprocessing. The capacity addition in Suwa is
June 16, 2022 10:55
GC Aesthetics® Announces Growth and Expansion in Brazil
GC Aesthetics®, Inc. (GCA), a privately-held medical technology company providing Women Healthcare Aesthetic and Reconstructive Solutions, has announced today, its growth and expansion plans for the B
June 15, 2022 15:40
ValGenesis Acquires 4Tune Engineering, Extends Product Portfolio with Best-in-Class Risk Management and Continuous Process Verification Software Platforms
ValGenesis, Inc., the market leader in enterprise Validation Lifecycle Management Systems (VLMS), has acquired Portugal-based 4Tune Engineering (4TE), a leader in manufacturing sciences and technologi
25 per page50 per page75 per page100 per page